These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26302237)

  • 21. The Distinctive Genomic Landscape of Giant Congenital Melanocytic Nevi.
    Stark MS; Tell-Martí G; Martins da Silva V; Martinez-Barrios E; Calbet-Llopart N; Vicente A; Sturm RA; Soyer HP; Puig S; Malvehy J; Carrera C; Puig-Butillé JA
    J Invest Dermatol; 2021 Mar; 141(3):692-695.e2. PubMed ID: 32800874
    [No Abstract]   [Full Text] [Related]  

  • 22. Hereditary spastic paraplegia masqueraded by congenital melanocytic nevus syndrome: Dual pathogenesis of germline non-mosaicism and somatic mosaicism.
    Sakaguchi Y; Uehara T; Sasaki M; Fujimura K; Kishi K; Kosaki K; Takenouchi T
    Eur J Med Genet; 2020 Apr; 63(4):103803. PubMed ID: 31698101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Giant congenital melanocytic naevus with a novel CUX1-BRAF fusion mutation treated with trametinib.
    Molho-Pessach V; Hartshtark S; Merims S; Lotem M; Caplan N; Alfassi H; Maly A; Goldstein G; Muskatel RS
    Br J Dermatol; 2022 Dec; 187(6):1052-1054. PubMed ID: 36030465
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular Genomic Profiling of Melanocytic Nevi.
    Colebatch AJ; Ferguson P; Newell F; Kazakoff SH; Witkowski T; Dobrovic A; Johansson PA; Saw RPM; Stretch JR; McArthur GA; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Waddell N; Scolyer RA; Wilmott JS
    J Invest Dermatol; 2019 Aug; 139(8):1762-1768. PubMed ID: 30772300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DDR2 mutation in a spilus-type giant congenital melanocytic nevus.
    Gallo-Pineda G; Ortiz-Prieto A; Villegas-Romero I; Navarro-Navarro I; Linares-Barrios M
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):e793-e794. PubMed ID: 35620941
    [No Abstract]   [Full Text] [Related]  

  • 26. Hiding in plain sight: molecular genetics applied to giant congenital melanocytic nevi.
    Etchevers HC
    J Invest Dermatol; 2014 Apr; 134(4):879-882. PubMed ID: 24646799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic analysis of adult case of ocular surface giant congenital melanocytic nevus and associated clinicopathological findings.
    McGrath LA; Palmer JM; Stark A; Glasson W; Warrier SK; Whitehead K; Hamilton H; Brooks K; Johansson PA; Hayward NK
    Ophthalmic Genet; 2020 Dec; 41(6):616-620. PubMed ID: 32814477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital spilo-melanocytic nevus: a speckled lentiginous naevus and a spilus-like congenital melanocytic nevus in close proximity.
    Lipsker G; Lipsker D
    J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):e926-e927. PubMed ID: 35771121
    [No Abstract]   [Full Text] [Related]  

  • 29. NRAS-mutated melanocytic BAP1-associated intradermal tumor (MBAIT): a case report.
    Blokx WA; Rabold K; Bovenschen HJ; Ligtenberg MJ; Mensenkamp AR; van Lijnschoten G; van Zelst-Stams WA; Groenen PJ
    Virchows Arch; 2015 Jan; 466(1):117-21. PubMed ID: 25342144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An update on congenital melanocytic nevus syndrome: A case report and literature review.
    Abdulmajid L; Bosisio FM; Brems H; De Vlieger G; Garmyn M; Segers H; Demaerel P; Segers K; Jansen K; Lagae L; Verheecke M
    J Cutan Pathol; 2021 Dec; 48(12):1497-1503. PubMed ID: 34255877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local Inhibition of MEK/Akt Prevents Cellular Growth in Human Congenital Melanocytic Nevi.
    Rouillé T; Aractingi S; Kadlub N; Fraitag S; How-Kit A; Daunay A; Hivelin M; Moguelet P; Picard A; Fontaine RH; Guégan S
    J Invest Dermatol; 2019 Sep; 139(9):2004-2015.e13. PubMed ID: 31059696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of Congenital and Deep Penetrating Nevus by Acquisition of β-Catenin Activation.
    Garrido MC; Nájera L; Navarro A; Huerta V; Garrido E; Rodriguez-Peralto JL; Requena L
    Am J Dermatopathol; 2020 Dec; 42(12):948-952. PubMed ID: 32568834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naevus spilus as a precursor of cutaneous melanoma: report of a case and literature review.
    Borrego L; Hernandez Santana J; Baez O; Hernandez Hernandez B
    Clin Exp Dermatol; 1994 Nov; 19(6):515-7. PubMed ID: 7889678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mosaic RASopathies: phenotypic and genotypic differentiation of naevus spilus-type congenital melanocytic naevus and segmental naevus spilus.
    Lee SB; Hummel HM; Krengel S; Enk A; Haenssle HA
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1244-6. PubMed ID: 25882553
    [No Abstract]   [Full Text] [Related]  

  • 35. Melanoma in congenital melanocytic naevi.
    Kinsler VA; O'Hare P; Bulstrode N; Calonje JE; Chong WK; Hargrave D; Jacques T; Lomas D; Sebire NJ; Slater O
    Br J Dermatol; 2017 May; 176(5):1131-1143. PubMed ID: 28078671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ulcerated sclerotic giant congenital melanocytic naevus: case report and review of the literature.
    Hernandez-Martin A; Torrelo A; Echevarria C; Contreras F
    Clin Exp Dermatol; 2007 Sep; 32(5):529-32. PubMed ID: 17459068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal, sebaceous, and melanocytic nevoid proliferations are spectrums of mosaic RASopathies.
    Luo S; Tsao H
    J Invest Dermatol; 2014 Oct; 134(10):2493-2496. PubMed ID: 25219651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis.
    Salgado CM; Basu D; Nikiforova M; Hamilton RL; Gehris R; Jakacki R; Panigrahy A; Yatsenko S; Reyes-Múgica M
    Melanoma Res; 2015 Oct; 25(5):453-60. PubMed ID: 26266759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling.
    Pawlikowski JS; Brock C; Chen SC; Al-Olabi L; Nixon C; McGregor F; Paine S; Chanudet E; Lambie W; Holmes WM; Mullin JM; Richmond A; Wu H; Blyth K; King A; Kinsler VA; Adams PD
    J Invest Dermatol; 2015 Aug; 135(8):2093-2101. PubMed ID: 25815427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.
    Lim YH; Ovejero D; Sugarman JS; Deklotz CM; Maruri A; Eichenfield LF; Kelley PK; Jüppner H; Gottschalk M; Tifft CJ; Gafni RI; Boyce AM; Cowen EW; Bhattacharyya N; Guthrie LC; Gahl WA; Golas G; Loring EC; Overton JD; Mane SM; Lifton RP; Levy ML; Collins MT; Choate KA
    Hum Mol Genet; 2014 Jan; 23(2):397-407. PubMed ID: 24006476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.